Pharmacy Podcast Network

This episode we look at some of the latest compounding news, and then we’ve got a deep dive into state-level legislation with the Leading Ladies of Pharmacy Compounding Advocacy. What bills are being introduced? What do they really mean when you read the detail? How will they affect state policies, and what could come next? And, of course, how are APC and compounding pharmacies fighting back against the bad bills that put patients at risk? If you’re a compounder, if you have patients who use compounded medications, or if you’re a patient yourself, you’ll want to hear this. Links from the podcast: The FDA statement on excluding GLP-1s from bulk compounding: https://fllw.me/491oGl3 FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C (part 1), https://fllw.me/4nxd13G (part 2) Is It Legit? to find a state-licensed compounding pharmacy: https://a4pc.org/isitlegit Join APC! https://a4pc.org/join

Birth Rights, Medical Bills & Maternal Advocacy with Andi Orwoll, Esq In this powerful episode of MaternalRx, Dr. Danielle Plummer sits down with Nevada attorney and founder of Your Legal Doula, Andi Orwoll, to discuss the often-overlooked legal and financial realities families face during pregnancy, birth, and postpartum recovery. From navigating IVF paperwork and unexpected C-sections to battling insurance denials and understanding birth rights, Andi shares how her own journey into motherhood inspired her to create a legal advocacy practice specifically for pregnant and postpartum families. This conversation explores the intersection of maternal health, patient advocacy, legal protections, informed consent, workplace rights, and the emotional toll of navigating the U.S. healthcare system during one of life’s most vulnerable seasons. In this episode, we discuss: - Why birth rights matter - The legal gaps in maternal healthcare - Insurance denials and surprise medical bills - IVF, fertility care, and the hidden administrative burden - Informed consent and patient advocacy during labor - The Pregnant Workers Fairness Act (PWFA) - The midwifery model of care vs. traditional obstetric care - Maternal mental load and postpartum vulnerability - Why tracking medical records, bills, and receipts matters - Navigating medical bills and insurance appeals Key Takeaways: “Policy never overrides your rights.” Andi explains how many patients are intimidated in medical settings and may not realize they have the legal right to informed consent, respectful care, and bodily autonomy during pregnancy and birth. Birth experiences matter. Even when outcomes are medically positive, the emotional and psychological experience of birth can have lasting effects. Advocacy, education, and support can profoundly shape those experiences. The paperwork burden is real. Pregnancy often comes with overwhelming administrative tasks: insurance appeals, billing disputes, maternity leave paperwork, provider reimbursements, and more — all during an emotionally and physically vulnerable time. Midwives, doulas, OBs, pharmacists, and lawyers all have a role. Maternal healthcare works best when it’s collaborative. This episode highlights the importance of interdisciplinary support systems for pregnant families. Track everything. One of the biggest practical pearls from this episode: keep copies of: - Medical bills - Insurance explanations of benefits (EOBs) - Receipts - Appointment dates - Correspondence with insurance companies - Workplace accommodation requests Documentation can make all the difference if problems arise later. About the Guest: Andi Orwoll is a Nevada-licensed attorney and founder of Your Legal Doula, a legal advocacy practice focused on supporting families navigating pregnancy, birth, postpartu

A leadership-level discussion on why drug shortages and supply instability continue to challenge pharmacy, and what executives must understand about operations, compliance, sourcing, and strategy to build a more durable supply chain.

In this episode of the PBM Reform Podcast, host Greg Reybold, Vice President and General Counsel at APCI, welcomes Josh Golden, Senior Vice President of Strategy at Judi Health and a nationally recognized voice in Pharmacy Benefit Manager reform. With more than 20 years of healthcare consulting experience, Golden brings deep expertise in vendor procurement, contract negotiation, plan design, and benefit strategy for large employers, government entities, and unions. Together, Reybold and Golden examine the financial models behind today’s PBM industry and why true transparency remains so difficult for employers, plan sponsors, patients, and pharmacies. The conversation explores how current PBM arrangements often benefit the PBMs more than the employers paying for coverage or the patients relying on their prescription benefits. Golden explains why auditing PBM contracts, rebate structures, spread pricing, administrative fees, pharmacy networks, and formulary decisions is essential to understanding the real economics of prescription drug benefits. This episode also addresses a growing concern in healthcare: PBM steering behavior. Are patients being quietly pushed toward specific formularies, specific pharmacies, and restricted networks that operate like closed networks without being clearly disclosed? Reybold and Golden discuss how this behavior can limit patient choice, disadvantage independent pharmacies, and distort the stated goal of lowering drug costs. The discussion also tackles the role of federal reform efforts, including whether the Appropriations Act represents meaningful PBM accountability or whether it risks becoming another layer in the broader shell game surrounding PBM reform. Finally, the episode asks one of the most important questions in pharmacy policy today: should PBMs own pharmacies? If vertical integration is promoted as a way to lower drug costs, where is the proof — and who actually benefits? Transparency, Auditing, and the PBM Shell Game | PBM Reform

This is a corporate-focused, conversational interview between Pharmacy Podcast Network Host, Todd Eury and Stephen Beckman, CEO of YARAL Pharma. The discussion explores YARAL Pharma’s unique approach to the U.S. generics market, its commitment to innovation and accessibility, and the company’s philosophy of “Doing Things Differently” by redefining what it means to be a generics partner. Stephen Beckman also shares insights into YARAL’s growth and key milestones since launching its first product in 2023, including the expansion of its product portfolio, investment in business development, and focus on building a strong company culture.

On this episode of This Week in Pharmacy, we examine three major forces shaping healthcare today: the global impact of conflict on health security, the continued evolution of personalized specialty pharmacy care, and the over-the-counter products patients rely on most.   We open the show with Aman Gupta, Managing Partner, Asia-Pacific at SPAG FINN Partners, and contributor author at MedikaLife. Aman joins TWIRx to discuss his latest MedikaLife article, which argues that global conflict is quietly undermining health security by redirecting funding, attention, and infrastructure away from healthcare and toward defense priorities.   As military spending rises, health systems—especially in low- and middle-income countries—face growing pressure from shrinking access, rising costs, workforce shortages, disrupted supply chains, weakened disease surveillance, and reduced emergency preparedness. Conflicts in Ukraine, Gaza, and Sudan demonstrate how attacks on healthcare systems, displacement, malnutrition, and shortages of essential medicines can rapidly turn health access into a survival issue. Aman urges policymakers to treat health as strategic security infrastructure, not as a secondary social expense.   TWIRx also gives a special shout out to the Indian Pharmaceutical Association, recognizing its continued leadership and advocacy for the pharmacy profession.   Next, we welcome Dr. Chris Antypas, PharmD, with Perigon Pharmacy 360, for a discussion on how specialty pharmacy is becoming increasingly personalized. As complex therapies continue to advance, pharmacists are playing a critical role in ensuring medications and treatment plans are customized to optimize patient care. We explore how technology, workflow processes, clinical expertise, and pharmacists who deeply understand specific disease states are essential to successful specialty pharmacy outcomes.   To wrap up the episode, returning guest Shanley Chien Pierce, Senior Editor, Health at U.S. News & World Report, joins us to review the latest OTC medicine and health product evaluations. Top-rated products include Children’s Delsym for coughs, Unisom for sleep, and Pedialyte for electrolytes, along with skincare favorites such as La Roche-Posay for retinol and Aquaphor for lip balm.   For the full list covering more than 128 categories, visit the U.S. News Best OTC Medicine & Health Products rankings.   Sponsored by Perigon Pharmacy 360 Listen & Subscribe Stay connected with This Week in Pharmacy and the Pharmacy Podcast Network for conversations with pharmacy leaders, healthcare innovators, policy experts, and industry voices shaping the future of care.

On this episode of the Counter Talk™ Podcast, host Jason Callori sits down with Bryan Lowe, Director of Government Relations at Cardinal Health, for a deep dive into the political landscape of 2026. As state legislators begin a new legislative session, Jason and Bryan dive into state-level priorities, anticipated challenges and the key issues already dominating the agenda, including PBM reform, state budgets, and evolving scope of practice discussions.   Tune in for essential insights into the legislative year ahead!

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part five of our six part series! We'd like to thank PantherX Rare for sponsoring this episode! On this episode we interview: Katie DiLorenzo, PharmD SVP - PantherRx Austin Russian - PantherRx Autumn Santeler -  Polar Tech Industries Ben Heiser - Lumicera Health Services Caroline Girardeau, PharmD, MBA ACHC Chris Stewart - Petauri Natalie Bedford - McKesson

What's the difference between marketing and advertising and why does it matter for your pharmacy?  In this episode of the Bottom Line Pharmacy Podcast, Austin Murray sits down with Bruce Kneeland, longtime independent pharmacy advocate and host of the Pharmacy Crossroads podcast, for a candid conversation about what it really takes to grow an independent pharmacy in today's competitive landscape. Bruce shares his fascinating journey from a chance job posting at BYU that landed him in Fargo, North Dakota, to senior roles at Health Mart, AmerisourceBergen, and eventually becoming a consultant and road-tripper who has visited pharmacies coast to coast. In this episode, Bruce and Austin cover: - Marketing vs. advertising and why confusing the two is costing pharmacies patients - The word-of-mouth myth and why relying on it alone is "killing you slowly" - Messaging that connects how to talk about complex services like compounding in language patients actually understand - The B2B opportunity and why your real customer for compounding and specialty services might be the prescriber, not the patient And more!

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part four of our six part series! We'd like to thank JB Consulting for sponsoring this episode!   On this episode we interview: Shaun Jensen - JB Consulting Group Lindsay Greenleaf - ADVI Magnar Kvilhaug - Odin Pharmacy Innovations LLC Marina Allen - RxAccess Partners Matt Hare - CoverMyMeds Richard Brook - Better Health Worldwide Valerie Mondelli and Colin Banas - DrFirst

On this episode of This Week in Pharmacy, we examine two major forces reshaping the profession: the unfinished business of pharmacist provider status and the legal landscape around direct-to-consumer pharmaceutical distribution. In part one, Erik Abel, PharmD, MBA, discusses his May 2026 analysis, “So Pharmacists Want to Be a Provider: Where the Profession Lost Its Way and Perhaps a Path to Get Back.” Abel argues that pharmacy’s provider-status challenge is not a lack of clinical evidence, but a lack of operational infrastructure: credentialing, payer contracting, revenue cycle management, interoperability, and scalable business models. In part two, Darshan Kulkarni, PharmD, Esq., joins the show to discuss direct-to-consumer pharmaceutical distribution, legal risk, regulatory scrutiny, telehealth-linked prescribing, manufacturer strategy, and what pharmacists need to understand as drug distribution moves closer to the patient. This week in pharmacy news, Pittsburgh-area pharmacies continue to face uneven access to Adderall and other ADHD medications, years after the FDA first identified shortages in 2022. Patients are still calling multiple pharmacies, switching medications, rationing doses, or going without treatment as availability varies by dosage, formulation, manufacturer, and wholesaler. Pharmacists are also using medication therapy management to protect older adults from preventable medication-related harm. MTM reviews can identify risky prescriptions and OTC products, including diphenhydramine, duplicate therapies, drug interactions, and long-term proton pump inhibitor use that may need reassessment. In 340B news, CVS Health is facing federal lawsuits from major health systems alleging CVS Specialty and WellPartner improperly retained approximately $250 million in savings that should have gone back to covered entities. The litigation adds pressure to debates over PBM integration, contract pharmacy arrangements, and 340B transparency. On Capitol Hill, lawmakers are pressing the Department of Defense to commit to annual audits of the TRICARE pharmacy contract as concerns continue around PBM conflicts of interest, reimbursement practices, network adequacy, and access for independent and community pharmacies.

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part three of our six part series! We'd like to thank Pergion Pharmacy 360 for sponsoring this episode! Chris Antypas PharmD - Perigon Pharmacy 360 Chris Corsi - CassianRx Christen Roy - Inovalon Robert Ojeda - K&B Pharmacy Associates

Today’s guest and I fundamentally agree on the basic premise of the body’s innate wisdom and capacity to heal, especially when we view it in a broader ecological context. According to him, infertility doesn't mean the body is broken; it's actually making intelligent, adaptive, and protective decisions made by the 4 foundational systems of the body that created life in the first place based on environmental conditions, resources, safety, and energy.  Nick Dorsey, FDN-P, is a systems-based fertility and health educator, biochemist, and former chemistry educator who helps couples understand why fertility shuts down even when labs look normal and they're doing all the right things. With a Master's in biochemistry and over a decade teaching chemistry, physics, and environmental science, he translates complex biology into a clear understanding of how the body makes decisions.  Nick’s research and experience supports that the body isn't broken, it's adapting intelligently to depletion, toxicity, and chronic stress, and symptoms like inflammation, fatigue, anxiety, gut dysfunction, and unexplained infertility are protective signals from a system in survival mode. Nick teaches health through the Four Pillars of biological readiness: the microbiome as the environmental interface, mitochondria as energy and resource allocators, minerals as the electrical and enzymatic stabilizers of physiology, and the nervous system as the regulator of safety and coherence.  Rather than chasing symptoms, his work restores these systems so the body can repair, regulate, and reproduce when conditions are biologically appropriate. Functional labs reveal patterns of adaptation that explain why the body is saying not now, and what it needs next. Nick works with individuals and couples through high-touch, data-informed programs, with a long-term commitment to healthy pregnancies, births, and families across generations. He's a father of two with another on the way, both born at home, and long before biochemistry he spent most of his life teaching, coaching, and supporting children, including leading a youth ministry for kids with disabilities.  Connect with Nick  via: Email: [email protected]  IG: @FunctionalChemistry YT: @FunctionalChemistry10

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part two of our six part series! We'd like to thank Nested Knowledge for sponsoring this episode!   On this episode we interview: Keith Kallmes - Nested Knowledge Hannah Baxter and Andrew Rouff, MMIT - The Dedham Group Heather Bonome - URAC Jeremy Richardson - Gifthealth Joe Depinto - McKesson Johny Kello - MatchRx Shawn Griffin - URAC

This week, This Week in Pharmacy examines several stories shaping the business, clinical, and legal future of pharmacy practice. In TWIRx News from Pharmacy Times from Megan Maroney, PharmD, BCPP, FAAPP, focused on antidepressant use, withdrawal concerns, deprescribing, and shared decision-making. The key takeaway: patients should never stop antidepressants abruptly. Pharmacists can play a vital role in reducing stigma, educating patients, and supporting safe conversations about tapering, side effects, and long-term treatment. In health technology news, FDB research presented at the 2026 AMIA Amplify Informatics Conference found that patient-specific, risk-based medication guidance reduced pharmacy alert volume by 70% in a high-volume community pharmacy setting. The model consolidates alerts into one actionable message tied to the patient’s most relevant risk, helping reduce alert fatigue and improve workflow. Finally, we review a federal court ruling in Eli Lilly’s lawsuit against Houston-based Empower Pharmacy over compounded tirzepatide versions of Mounjaro and Zepbound. The judge dismissed key federal trademark and Texas unfair competition claims, while allowing other state claims to continue. Andy Crawford, with Keysource is back on TWIRx talking about the U.S. Supreme Court taking up Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., a case that could significantly affect generic drug competition. At issue is whether Hikma’s marketing materials and public communications around its generic version of Amarin’s fish oil-based cardiovascular drug improperly promoted a still-patented use. Hikma and the broader generic industry argue the case is about protecting “skinny label” rules, which allow generics to carve out patented indications while still bringing lower-cost medications to market. For pharmacists, the decision could influence generic availability, substitution confidence, pricing pressure, and how manufacturers communicate with providers and pharmacies. Thanks to our sponsors, CassianRx and IPC, for supporting independent pharmacy, innovation, and the future of patient-centered care.

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part one of our six part series! We'd like to thank Clearway Health for sponsoring this episode!   On this episode we interview:   Allison Arant - Clearway Health Jennifer Noonan - Accessia Health  Aleata Postell - CenterWell Derek Denise - Clearway Health Dr. Shafaat Pirani, PharmD, BCGP - Wellgistics Health Meghna Misra - Claritas Rx

In this episode of Executive Dose, Marc Essensa, CEO at IPC, joins the conversation to discuss what leadership looks like inside community pharmacy during one of the most pressured moments in the profession. The episode explores how vision, strategy, ethics, and creative thinking can help independent pharmacies not only survive, but compete and grow.  Marc and Stephen examine the realities facing pharmacy owners today, including reimbursement pressure, shrinking margins, labor challenges, operational overload, and the emotional toll of pharmacy closures. The discussion moves beyond day-to-day survival and focuses on what separates leaders who react from those who lead with clarity and discipline. The episode also highlights the importance of building a business model that can compete, using partnerships, technology, operational efficiency, and new service models to create long-term value. Marc also speaks to the role of business ethics and trust, emphasizing that in community pharmacy, leadership character is not optional — it is part of the business strategy. Key Topics Leadership under pressure in community pharmacy How pharmacy owners can lead with vision during uncertainty Strategic mistakes that weaken independent pharmacies Operational efficiency, differentiation, and growth opportunities The role of IPC in helping pharmacies compete Why ethics, transparency, and trust matter in pharmacy leadership Creativity, courage, and innovation in the future of community pharmacy

A strong marketing strategy depends on the variety and relevance of your content. In this episode, we dive into what a diverse content strategy is, why it matters, and how it can elevate your marketing efforts. We’ll highlight the key benefits of producing varied content, common pitfalls to avoid, and practical tips for integrating different content types across your channels. Tune in to learn how to engage your audience more effectively, strengthen your online presence, and make your marketing work harder for you.

Today’s guest on the podcast shares how to proactively preserve both one’s health span and “beauty span”: the visible vitality, confidence, and connection to self over time. We got into some juicy and controversial topics around aging and the beauty industry, as well sustainability. My guest asserts that aging is not a passive process, it is something we can actively manage. Her mission is to help people understand that beauty, energy, and longevity are interconnected. When you support the body at a cellular and hormonal level, you don’t just look better, you function better. Dr. Sofia Din is a board-certified Family Physician with over 25 years of medical experience and advanced training in Geriatrics. She began her career in hospital medicine and long-term care, where she served as a Medical Director, before shifting her focus from disease management to proactive longevity and anti-aging medicine. She is the Medical Director of Juvanni Medical P.C. in Westchester, New York, where she integrates aesthetics, hormonal health, and advanced non-surgical technologies to help patients navigate menopause, andropause, metabolic slowdown, and chronic skin failure. Dr. Din is also the author of Do We Really Need Botox? and the host of the podcast Bathroom Diaries, where she explores the science, psychology, and cultural dimensions of aging, beauty, and self-perception. Connect with Sofia via: — Juvanni Med Spa: Email: [email protected]  Website: Botox Guru at Juvanni Med Spa FB: Juvanni Med Spa IG: @drjuvanni YT: @DrJuvanni Twitter/X: @JuvanniMedSpa Linked In: Juvanni Medical — Dr. Sofia Din: FB: Sofia Din IG: @therealdrjuvanni YT: @DrJuvanni TikTok: @botoxguru Linked In: Sofia Din Podcast (Spotify): Bathroom Diaries w. Dr. Sofia Din — Minerva Life: YT: @minervalife6529 TikTok: @sofiadinmd Visit https://marinabuksov.com for more holistic content.  Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Sponsored by Rx4Route This Week in Pharmacy returns with a timely two-part episode focused on pharmacy operations, medication access, and the growing responsibility of healthcare communicators in the age of AI. In our first segment, we welcome Joseph Dymowski, PharmD, CEO of Centennial Pharmacy Services, and Doniyor Sattarov, Vice President of Operations at Rx4Route, for a conversation about expanding long-term care pharmacy at home. As more patients age in place, pharmacies must rethink delivery, logistics, documentation, and patient communication as essential parts of care. Delivery is no longer just a convenience. It is a critical extension of pharmacy services. Reliable routing, real-time tracking, and proof of delivery help pharmacies improve adherence, reduce operational friction, and build stronger trust with patients, caregivers, and providers. Expanding LTC pharmacy-at-home services, building scalable delivery workflows, improving route efficiency, using delivery technology to support compliance, and why logistics may become a major competitive advantage for pharmacies. This episode is sponsored by Rx4Route, pharmacy delivery software designed to help pharmacies streamline delivery operations, optimize routes, track orders, and improve proof-of-delivery workflows. In our second segment, we speak with **Vincent Grippi, CEO of Grippi Media, about the dangers of AI-generated misinformation and the higher standard required in healthcare communications. As AI becomes more common in content creation, communications professionals must protect accuracy, credibility, and patient trust. In healthcare, misinformation can influence clinical understanding, damage reputations, and create confusion across the industry. That is why content for healthcare professionals must be reviewed, verified, and guided by human judgment. AI misinformation in healthcare, responsible content development, source verification, editorial review, subject-matter expertise, and how communicators can use AI without sacrificing trust. This episode connects two critical forms of trust in pharmacy: operational trust at the patient’s door and informational trust across every communication channel. Featured Guests: Joseph Dymowski, PharmD— CEO, Centennial Pharmacy Services Doniyor Sattarov— Vice President of Operations, Rx4Route Vincent Grippi— CEO, Grippi Media

This episode we look at a bunch of statements from the FDA and from HHS Secretary Robert F. Kennedy, Jr. And of course there are peptides to talk about these days. Does anyone really know what’s going on with those? Our deep dive is a special one: Our guest is Al Carter, the CEO of the National Association of Boards of Pharmacy, and he gives us a totally different perspective on the regulatory landscape at the level that affects pharmacists every day. Links from the podcast: The latest FDA statement on DTE: https://fllw.me/4sL6zXw  The Coalition for Compounding Excellence’s first audit process guide (compounding records and quality control): https://fllw.me/3Oew1qr  FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C  National Association of Boards of Pharmacy: https://nabp.pharmacy  Join APC! https://a4pc.org/join

On this episode of the Cardinal Health™ Counter Talk™ Podcast, host Jason Callori explores the benefits of co-branding your pharmacy with the Medicine Shoppe International, Inc. (MSI) franchise. The episode features Tony Ibrahim, a multi-store owner with the Medicine Shoppe® Pharmacy network, and Lance Mindt, a MSI Franchise Business Consultant.   Tony and Lance discuss how pharmacies can benefit from co-branding their stores while maintaining their local brand identity through the co-branding model. Learn how independent pharmacies can preserve their local identity, streamline operations and foster growth while gaining the support and expertise of a national franchise.   Click here to learn more about co-branding.

Welcome back to PPN – The Precision Medicine Pharmacist. In part one of our series, Precision Psychiatry in Practice – A Pharmacist–Physician Collaboration, we explored how a collaborative approach can begin to reshape psychiatric care — building trust, aligning perspectives, and creating space for more personalized treatment. Today, we move deeper into what that looks like in real-world, integrative medicine psychiatry. I’m excited to welcome back Dr. Saba Arshad, joined by Dr. Afshan Khan, as we explore how their partnership brings together different clinical perspectives to care for the whole patient — not just symptoms, but the broader context of mental health, lifestyle, and individualized needs. In this episode, Precision in Practice: Real Stories, Real Results in Integrative Psychiatry, we focus on the human side of collaboration. How do two clinicians with different training and strengths come together to approach complex cases? What does shared decision-making really look like in practice? And how does this integrative model shape better patient outcomes? We’ll walk through real patient cases, explore the dynamics of their collaboration, and uncover how this partnership continues to evolve to meet patients where they are. If part one introduced the foundation, today’s episode brings that collaboration to life. Let’s dive in.

AI in healthcare is no longer a futuristic concept. It’s already answering the phones at your local CVS. We’re pulling back the curtain on how AI is currently being used in pharmacy practice, from encrypted "VA GPT" systems for note-writing to controversial new phone bots that some patients claim are a "stain on society". We dive into the big news of the CVS and Google Cloud partnership to launch Health100, a platform designed to integrate your refills, copays, and even wearable health data into a single AI-driven hub. While the promise of centralized care sounds like a dream, the "real-world" experience can feel like a nightmare. We react to a brutal Reddit thread and even call a CVS live to demonstrate the frustration of wrestling with a robot that refuses to transfer you to a human. Whether you're a "tinfoil hat" wearer worried about data leaks or someone just trying to get a prescription after surgery, you need to hear the clinical and personal reality of the AI takeover. This show is intended for educational and informational purposes.

TWIRx News: Congratulations to Logan Eury and his new wife Emily, who were married today, May 1, 2026! This C.O. Bigelow Collab Introduces the 188-Year-Old Pharmacy to a New Generation Abbode is taking over the Carolyn Bessette-Kennedy-approved shop for a month-long pop-up. https://fashionista.com/2026/05/co-bigelow-abbode-pop-up-carolyn-bessette-impact Renewed interest in C.O. Bigelow shows how nostalgia, Carolyn Bessette-Kennedy’s minimalist style, and “quiet luxury” storytelling can drive brand attention, foot traffic, and retail sales. Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit https://www.managedhealthcareexecutive.com/view/q-a-mayo-clinic-leaders-share-strategies-for-managing-high-cost-drugs-without-breaking-the-bank-asembia-axs26-summit Mayo Clinic leaders say managing high-cost drugs requires structured formulary review, multidisciplinary collaboration, and careful evaluation of safety, efficacy, financial impact, reimbursement, and site-of-care decisions. Where Gross-to-Net Pressure Actually Lives After Launch Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. https://www.drugchannels.net/2026/05/where-gross-to-net-pressure-actually.html The article explains that gross-to-net pressure comes from rebates, discounts, fees, and policy shifts. As net pricing grows, manufacturers, PBMs, and pharmacies must rethink traditional rebate-driven strategies. Today’s featured guest: Dr. Ndidiamaka Okpareke, PharmD for Congress Dr. Ndidiamaka “Didi” Okpareke is a pharmacist, entrepreneur, and congressional candidate in New Mexico’s 1st District. A first-generation Nigerian-American and University of New Mexico College of Pharmacy graduate, she founded a compounding pharmacy and brings nearly two decades of patient care experience to public policy. Her campaign focuses on healthcare access, rising costs, provider shortages, economic growth, and strengthening opportunity for future generations. Special Episode: TJM Labs and AI-Driven Pharmacy Operations This episode features Bhavesh Patel, PharmD, CEO of Carepoint Pharmacy, and Jonathan Adly, PharmD, MBA, CEO of TJM Labs, discussing how AI-powered automation can help pharmacies manage rising prescription volume, staffing challenges, and workflow complexity. TJM Labs uses AI “digital workers” to automate prescription intake, data entry, and patient communication—reducing burnout, improving accuracy, and allowing pharmacy teams

Congratulations to Logan Eury and his new wife Emily, got married today, May 1, 2026!  This C.O. Bigelow Collab Introduces the 188-Year-Old Pharmacy to a New Generation Abbode is taking over the Carolyn Bessette-Kennedy-approved shop for a month-long pop-up. https://fashionista.com/2026/05/co-bigelow-abbode-pop-up-carolyn-bessette-impact  The article highlights how a pop-up and renewed interest in C.O. Bigelow has been fueled by the cultural resurgence of Carolyn Bessette-Kennedy’s minimalist style, amplified by media and social buzz. This renewed attention has driven significant foot traffic and sales, showing how storytelling, nostalgia, and “quiet luxury” aesthetics can translate into real retail impact.   Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit https://www.managedhealthcareexecutive.com/view/q-a-mayo-clinic-leaders-share-strategies-for-managing-high-cost-drugs-without-breaking-the-bank-asembia-axs26-summit Mayo Clinic leaders emphasize that managing high-cost drugs requires clear definitions, structured formulary review processes, and multidisciplinary collaboration to balance cost, access, and clinical value. They highlight the importance of evaluating safety, efficacy, financial impact, and site-of-care decisions together, while noting that non-340B systems face increasing pressure from rising costs and reimbursement constraints. Ultimately, success depends on stronger alignment between health systems, manufacturers, and payers to sustain access without compromising quality of care.  Where Gross-to-net Pressure Actually Lives After Launch Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. https://www.drugchannels.net/2026/05/where-gross-to-net-pressure-actually.html The article explains that “gross-to-net pressure” isn’t driven by a single factor, but by a combination of rebates, discounts, fees, and policy changes that continue to reshape how drug pricing actually works behind the scenes. As the industry shifts toward a “net pricing” model, traditional rebate-driven strategies are weakening, forcing manufacturers, PBMs, and pharmacies to rethink how value and profits are generated. Today's featured guest is Dr. Ndidiamaka Okpareke PharmD for Congress Dr. Ndidiamaka “Didi” Okpareke, PharmD, is a pharmacist, entrepreneur, and political candidate running for Congress in New Mexico’s 1st Congressional District. A first-generation Nigerian-American, she built her career in healthcare

Tennessee lawmakers have passed a major pharmacy reform bill aimed at pharmacy benefit managers, or PBMs, by barring companies from owning both a PBM and a pharmacy. The legislation is widely seen as targeting CVS Health, which owns Caremark and operates pharmacies across the state. Supporters say the bill is designed to curb vertical integration, restore fair competition, and protect independent pharmacies from reimbursement practices they view as harmful to patient access and community pharmacy survival. CVS has pushed back hard, warning that the new law could force it to shut down its 134 Tennessee pharmacy locations and trigger a legal challenge. The company argues the measure would reduce access for patients and does not directly address broader PBM issues like pricing or formularies. This Tennessee fight reflects a larger national battle over PBM reform, pharmacy ownership, market power, and the future of prescription drug access.

Clinical Pearls, Pain Pod edition: Pain Pearls Part 2 (of many) with Dr. Sing Ping Chow, PharmD as we discuss methadone, buprenorphine, gabapentin, pain pharmacists, AI, and beyond! A cornucopia of pain conundrums and potential solutions and/or tools to help mitigate. All here, nicely packaged, randomly, in one episode of the Pain Pod! One of many more to come, in a miniseries titled: “Pain Pearls”, only here on the Pain Pod! Come one, come all, to the Pain Pod!!! P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us or LinkedIn to directly reach Mark and have your voice heard!

What does it actually mean to be healthy if your labs come back "normal" but you still feel terrible? For too many high-achieving professionals, that question goes unanswered for years. Today's guest knows that experience firsthand and has built her entire practice around closing that gap. Ekat is a Nutritional Therapy Practitioner (NTP), Restorative Wellness Practitioner (RWP), and Board-Certified Integrative Nutrition Health Coach. After 16+ years on Wall Street, she experienced firsthand what chronic stress, long hours, and burnout can do to a body, and what conventional medicine often misses when it does.  Through her virtual practice, Healthfully Ekat, she helps busy, high-achieving women uncover the root causes behind persistent digestive issues, hormonal imbalances, and chronic fatigue using functional lab testing, personalized nutrition, and holistic lifestyle strategies. Her message is as straightforward as it is powerful: you're only going to be as successful as your health allows you to be. In this episode, we talk about what it really takes to stop guessing and start understanding what your body actually needs, so your energy, gut, and hormones can work for you instead of against you. In this episode, we cover: • Why "normal" labs don't always mean optimal health • The connection between chronic stress, gut health, and hormonal chaos • How functional lab testing changes the root cause conversation • The microbes we often ignore but shouldn’t (including parasites!) • What high-performing professionals consistently get wrong about their health • Why true success requires your body to keep up with your ambition Connect with Healthfully Ekat via: Email: [email protected]  Website: https://www.healthfullyekat.com/  IG: @healthfully.ekat Visit https://marinabuksov.com for more holistic content.  Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Guests: Gil Bashe Chair Global Health and Purpose at FINN Partners Maya Hajizada Chief Revenue Officer at Rx2Go C. Daniel Mullins Professor at University of Maryland School of Pharmacy Mina G Yacoub PharmD BCPS Founder & CEO at Qik Productions

This is the Pharmacy Profit Summit Live Recap Show! Welcome to Part One. Pharmacy owners from across the US have come together to learn ways to improve their pharmacy's profit and bring better value to their patient's. The Pharmacy Podcast Network brings you this exclusive "man on the street" coverage of the show with interviews hosted by Todd Eury talking to the attendees, speakers, and vendors. In this episode, we hear interviews with: Pete Nagel - CurifyLabs Christopher Flores - Payment Processing Doug Soupon - RxOneShop Fiona Sartoretto Verna Omar - Utopia Pharmacy

“My doctor says it’s safe, but Google says it’s not… what do I do?” It’s the reality so many pregnant and breastfeeding moms face when they’re given conflicting medication advice.  In this episode, consulting pharmacist Dr. Danielle Plummer and clinical pharmacist Dr. Tara Birch pull back the curtain on pregnancy medication confusion and why it happens. As Tara puts it, “Pharmacists need to be utilized more than they are. We are medication specialists.”  The core message is clear: every mom needs a pharmacist as part of her care team. From preconception through the postpartum period, pharmacists bring the medication expertise that is often missing and can prevent confusion, errors, and unnecessary risk. From the overwhelm of choosing a prenatal vitamin to navigating mixed messages from providers and “Dr. Google,” they walk through what’s actually happening behind the scenes and how to make safer, more confident decisions. You’ll hear why “there is no one-size-fits-all prenatal vitamin,” how postpartum needs can increase during breastfeeding, and why a truly collaborative care team leads to better outcomes for both mom and baby. If you’ve ever second-guessed a medication, felt confused by conflicting advice, or wished you had a clear, trusted voice guiding you, this conversation will change how you approach your care. What You’ll Learn: - Why pharmacists are underused in maternal care - How to handle conflicting medication advice - How to choose the right prenatal vitamin - Why postpartum nutrition matters - The risks of relying on Google or AI for medication decisions - How collaborative care improves outcomes Expert Insights: - Pharmacists in Maternal Care: Pharmacists are medication experts but are often excluded from care teams. Including them improves safety and outcomes. - Conflicting Advice: Patients often receive mixed guidance from providers. Pharmacists help clarify evidence-based decisions. - Prenatal Vitamins: Not one-size-fits-all. Needs vary by diet, genetics, and symptoms. - Postpartum Nutrition: Nutrient needs may increase after delivery, especially during breastfeeding. - Gaps in Care: Hospital care is collaborative. Outpatient care is fragmented, creating safety risks. - Preconception Planning: Medication review before pregnancy can prevent first-trimester risks. Connect with Dr. Tara Birch: https://themotherbabypharmacist.com www.instagram.com/themotherbabypharmacist/ Phone/Text: 321-609-5424 Connect with Dr. Danielle Plummer: www.HGPharmacist.com linkedin.com/in/daniellerplummer

In this episode, we explore YARAL Pharma’s latest move to expand patient access to prescription topical patches through a new collaboration with UpScriptHealth. The partnership brings YARAL’s prescription topical treatments to a direct-to-consumer telehealth platform, giving patients a way to consult with licensed clinicians online and, when appropriate, receive prescriptions through participating pharmacies. The announcement reflects a broader shift in how pharmaceutical manufacturers are using digital health channels to improve convenience, affordability, and access to care.  We also examine what this means for the evolving pharmacy and telehealth landscape. YARAL Pharma said the collaboration supports its focus on continuity of supply, quality, customer service, and broader access to generic medicines, while UpScriptHealth highlighted its long-standing role in direct-to-patient telehealth services and its history of helping patients access care and prescriptions through online channels.  What You’ll Learn in This Episode: YARAL Pharma’s prescription topical patches are now available through UpScriptHealth’s telehealth platform. Patients can use the platform to connect with licensed healthcare providers virtually, determine eligibility, and potentially receive a prescription fulfilled through participating pharmacies. YARAL described the collaboration as part of its effort to expand access to affordable generic medicines through digital channels.  The episode also highlights the companies behind the announcement. YARAL Pharma is the U.S. generics subsidiary of IBSA, and UpScriptHealth describes itself as a direct-to-patient telehealth company that has helped facilitate more than two million prescriptions and works with a network of hundreds of physicians.  Key Discussion Points:  YARAL Pharma’s prescription topical patches are now offered through UpScriptHealth’s telehealth platform.   The partnership creates a direct-to-consumer path for online consultation and prescribing, when clinically appropriate.   YARAL says the move strengthens patient convenience and supports access to affordable generic treatment options.   UpScriptHealth brings an established national telehealth network and direct-to-patient infrastructure to the collaboration.   The announcement signals continued momentum in telehealth-enabled prescription access and digital pharmaceutical distribution. This last point is an inference based on the stated goals and structure of the partnership.

Welcome to the Pharmacy Podcast Network's special 3-Part series on the coverage of the American Pharmacist Association's Annual Conference event held in Los Angeles, California on March 27-31st. In this series, you'll hear from 4 key social media influencers having a massive impact on Pharmacy Advocacy, innovators exploring the advancing technology and use of AI in Pharmacy, and more! In this episode, we hear from: Stephen Beckman - Yaral Pharma Kati Forbes, PharmD Robbie Abasi, PharmD, Xavier Hill, PharmD, and Sam Llona, PharmD - RxRated Podcast Katlyn - Student at University of Montanna Sakhi Gaurang Patel - CuraVoice   Thank you to Yaral Pharma and the Independent Pharmacy Cooperative (IPC) for sponsoring this episode!

TWIRx News: The FDA plans to remove 12 peptide bulk drug substances from Category 2 of the Section 503A compounding list after their nominations were withdrawn. For compounders, the key issue is that this change does not automatically make compounding these substances permissible, leaving pharmacies exposed to ongoing regulatory uncertainty until the FDA makes further decisions. A nationwide Class II recall has been issued for Xanax XR 3 mg tablets in 60-count bottles, lot 8177156, after the product failed dissolution testing. Pharmacists should immediately locate and quarantine affected stock while reminding patients not to stop benzodiazepine therapy suddenly without direction from a healthcare provider. Community pharmacies are taking on a larger role in wound care by serving as an accessible first point of contact for patients with minor injuries. Pharmacists can help assess wounds, recommend appropriate over-the-counter treatment, watch for warning signs of complications, and refer patients for higher-level care when needed. Special sponsor interview with Allison Arant with Clearway Health.  Featured interview with  the World's Leading Innovation Theorist John Nosta Guests & sponsors of today's TWIRx, Perigon 360 Pharmacy with Chris Antypas PharmD and ed Mills  And a bonus interview with Dr. Andy Krut PharmD, on Psychedelics (e.g., LSD, psilocybin, DMT)

This is the Pharmacy Profit Summit Live Recap Show! Welcome to Part One. Pharmacy owners from across the US have come together to learn ways to improve their pharmacy's profit and bring better value to their patient's. The Pharmacy Podcast Network brings you this exclusive "man on the street" coverage of the show with interviews hosted by Todd Eury talking to the attendees, speakers, and vendors. In this episode, we hear interviews with: Ross Miller - TJM Labs Bradly Davie - InBody Jonathan Tanner - BreathRox Ajay Mehra - UGO Rx Amanda Pritchett - Vaccine Connect

Welcome to the Pharmacy Podcast Network's special 3-Part series on the coverage of the American Pharmacist Association's Annual Conference event held in Los Angeles, California on March 27-31st. In this series, you'll hear from 4 key social media influencers having a massive impact on Pharmacy Advocacy, innovators exploring the advancing technology and use of AI in Pharmacy, and more! In this episode, we hear from: Kelli Stovall, RPh, EMBA, - IPC Amantha Bagdon - RxPost Dixie Leikach - PeerRx Dr Erin Parsons, PharmD - LSPedia Sally Rafie, PharmD Thank you to Independent Pharmacy Cooperative (IPC) for sponsoring this episode!

This Week in Pharmacy 04-10-2026 Sponsored by Outcomes and Independent Pharmacy Cooperative (IPC) On this episode of This Week in Pharmacy, we dig into another high-impact week across the profession with TWIRx news, practice transformation, oncology leadership, pediatric research innovation, and a look ahead to one of specialty pharmacy’s biggest gatherings of the year. This week’s episode is powered by our sponsors, Outcomes and Independent Pharmacy Cooperative (IPC), organizations continuing to support independent pharmacy innovation, patient engagement, and pharmacy performance. In the TWIRx News segment, we cover four important stories shaping the national conversation in pharmacy. First, we discuss the federal fraud case involving a Dearborn Heights pharmacy owner who pleaded guilty in a $1.9 million health care fraud scheme. According to the U.S. Department of Justice, Rabih Hamdan admitted to conspiring to submit false claims for prescription drugs that were either medically unnecessary or never actually dispensed, impacting Medicare, Medicaid, and Blue Cross Blue Shield of Michigan. Federal prosecutors say the fraudulent claims totaled at least $1.9 million over a five-year period. Next, we look at oncology pharmacy leadership through the lens of Amy Seung, who is stepping into the HOPA presidency during a period of rapid acceleration in cancer care. In Pharmacy Times, Seung describes a practice environment where new approvals, indications, toxicity data, and clinical questions are arriving weekly or even daily. She positions HOPA as a key bridge between emerging science and real-world implementation, with this year’s conference emphasizing bispecific therapies, real-world evidence, supportive care, and toxicity management. We also spotlight a powerful research update from the UNC Eshelman School of Pharmacy, where professor David Drewry and student researchers are advancing work on diffuse intrinsic pontine glioma (DIPG), an aggressive pediatric brain cancer with limited treatment options and an average life expectancy of about one year after diagnosis. The team is using an open-science model to accelerate discovery while keeping future therapies more affordable, and they are working with M4K Pharma to advance an ALK2 inhibitor toward a Phase 1 clinical trial. Finally, we feature a practice transformation story from Drug Topics: Gregg Jones, MBA, RPh, made the leap from corporate pharmacy leadership to launching Compass Core Pharmacy, described as Rhode Island’s first cost-plus pharmacy model. The cash-only model focuses on generics, uses AI-driven ordering, serves a growing veterinary segment with more than 1,400 pet prescriptions, and operates as a CLIA-waived pharmacy offering point-of-care testing. It is a compelling example of how pharmacists are reengineering care delivery outside the traditional reimbursement framework. We are also getting ready for Ase

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Linda Clark and Brad Gallagher, Co-Leaders of Barclay Damon’s Health Care Controversies and Pharmacy Teams. They explore the rapidly evolving Pharmacy Benefit Manager (PBM) regulatory landscape and its impact on specialty pharmacies, offering key considerations for contracting and strategies to strengthen audit readiness and compliance. Linda and Brad also share practical guidance to help specialty pharmacies increasingly under pressure to manage their risk and position themselves for long-term success.

Independent pharmacists are facing increasing demands, and outdated payment processes add unnecessary friction. In this episode, Jason Callori speaks with Halston Prox, Founder and CEO of Tabz (formerly HealNow), and Cardinal Health Solution Manager Natalie Girardi about how modern payment technology is transforming independent pharmacies. The conversation highlights how Tabz helps streamline workflows, reduce payment friction, and enable faster compensation for pharmacists.

Today’s episode is one for the books! Seriously, if there’s one conversation you choose to listen to in my body of work, this is the one. My beautiful guest and I went deep into holistic healing in the truest sense of that term, through the lens of systems level change. We talked about what it takes to repair connection within ourselves, with one another, and with the more-than-human world, supporting pathways toward resilience, responsibility, and regenerative futures. Mor Keshet is an Integrative Eco-Art Therapist, systems thinker, and founder of TEVEL, a Nature-based healing platform advancing collective resilience in the face of ecological and societal disruption. Her work lives in the intersection of eco and trauma informed psychology, the science of awe, imagination and living systems. Mor’s framework origination has appeared in the journal Ecopsychology, Psychology Today and the Biomimicry Institute. Through TEVEL, Mor is building an ecosystem of regenerative care—developing programs, partnerships, and methodologies that position healing as relational, ecological, and culturally responsive. She works with individuals and institutions including The Nature Conservancy, University of Pennsylvania Weitzman School of Design, the American Art Therapy Association, Bard College and Smart City Expo USA. She is the creator of the Climate Emotions Mandala Project, developed in partnership with the Climate Mental Health Network,and holds leadership and teaching roles within the Climate Psychology Alliance – North America and the Climate Emotional Resilience Institute. At the heart of Mor’s work is a simple belief: “healing is not a solitary act - it is a shared unfolding.” Connect with Mor via: Email: [email protected]  Website: Mor Keshet IG: @morkeshetarttherapist Linked In: Mor Keshet

Welcome to the Pharmacy Podcast Network's special 3-Part series on the coverage of the American Pharmacist Association's Annual Conference event held in Los Angeles, California on March 27-31st. In this series, you'll hear from 4 key social media influencers having a massive impact on Pharmacy Advocacy, innovators exploring the advancing technology and use of AI in Pharmacy, and more! In this episode, we hear from: Jeffrey Gonzales - APhA Board Maurice Shaw, PharmD & Shane Jerominski, PharmD Richard Dang, PharmD Marsha Millonig, Rph Walter Oronsaye, PharmD, MS Thank you to YARAL Pharma for sponsoring this episode!

TWIRx – April 3, 2026 Co-Host: Jesse McCullough On today’s episode of This Week in Pharmacy – TWIRx, we welcome special co-host Jesse McCullough for a timely discussion focused on pharmacy innovation, compliance, advocacy, and the future of the profession. We begin with our featured sponsor segment presented by MatchRx, spotlighting two important voices in pharmacy technology and compliance. Johny Kello, CEO of MatchRx, joins the show alongside Riya Cao, CEO of LSPedia, for an important conversation centered on DSCSA readiness and the evolving world of pharmacy compliance. This discussion explores how pharmacies and supply chain stakeholders can better prepare for regulatory expectations, protect patients, and strengthen operational transparency through smarter compliance solutions. In the second half of the episode, we’re joined by Scott Brunner, CEO of the Alliance for Pharmacy Compounding (APC), for a recap of the Owner Summit 2026 and a look ahead at what’s developing on Capitol Hill. Scott shares insight into the policy landscape impacting pharmacy compounding, the priorities emerging from this year’s summit, and what pharmacy owners and industry leaders should be watching as legislative and regulatory conversations continue to evolve. This episode of TWIRx delivers a strong pulse on the profession—from compliance and interoperability to advocacy and the future of compounding pharmacy. Featured Guests: Johny Kello, CEO, MatchRx Riya Cao, CEO, LSPedia Scott Brunner, CEO, Alliance for Pharmacy Compounding (APC) Episode Topics: DSCSA and pharmacy compliance Supply chain visibility and readiness MatchRx and LSPedia collaboration in pharmacy compliance Owner Summit 2026 recap Capitol Hill updates impacting pharmacy compounding The future of compounding and pharmacy advocacy Sponsored by: MatchRx DSCSA Compliance and Compounding Leadership | TWIRx

On this episode of the PAIN POD, Mark Pain Guy Garofoli chats through the complexities of adjuvant pain medications including antidepressant and other medications from other medical condition treatment plans that overlap in mechanism with pain. Join the discussion right here, right now, on the Pain Pod. Come one, come all, to the Pain Pod!!!

I had an absolute blast sitting down with today’s unique guest, chatting on everything from seeking refuge, to exercise, to cancer, to cabbage (stick around to the end to get his amazing raw vegan cabbage recipe, you Easy Choices, Hard Life” - comes from lived experience and years of guiding people through transformation. What sets Jerzy apart is his ability to integrate physical training, creative expression, and psychological insight into a holistic approach to health and resilience. He emphasizes that emotional intelligence is a crucial element in overcoming life’s adversities, and that it can be practiced, cultivated, and mastered.  His three books, titled The Happy Body: Mastering Food, Exercise, and Rest Choices, are designed to help people embrace this path of strength, wisdom, and balance. The poetry book The Happy Body: Food For Your Soul helps with emotional eating. The Happy Body Virtues: Daily Practices for the Modern Stoic helps with emotional eating and self-regulation, while I Got This: The Art of Getting Grit helps with integrating the stories that contribute to building the skill of living a good life. Jerzy has been featured on The Tim Ferriss Show, delivered a Google Talk, and spoken on numerous wellness and longevity podcasts. His work has helped thousands around the globe adopt a sustainable path to strength and wellbeing. Currently, Jerzy is pursuing a PhD in Humanistic Psychology at Saybrook University, focusing on creativity, innovation, and leadership.  Connect with Jerzy via: Email: [email protected]  Website: https://thehappybody.com/  X: https://x.com/thehappybody?lang=en  YT: https://www.youtube.com/user/thehappybody  LinkedIn: https://www.linkedin.com/in/jerzy-gregorek-ab87475/

This episode is dedicated to the late Dr. Eric Geyer PharmD.  Feautured guest Chuck Melendi Disruptive Dialogue Special report from Bruce Kneeland Sponsored by TJM Labs and interview with Jonathan Adly This episode is sponsored by YARAL Pharma

This podcast discussion with Paul Shelton zeroes in on a pivotal shift underway in community pharmacy: the expansion of Long-Term Care at Home (LTC@Home) as both a care model and a sustainable business opportunity. Shelton frames LTC@Home not as a reinvention of pharmacy practice, but as a formalization and monetization of services pharmacies are already delivering—medication synchronization, adherence packaging, clinical oversight, caregiver support, and coordination with providers. The core issue isn’t capability—it’s structure and reimbursement. Many community pharmacies are بالفعل functioning as LTC providers informally, but without the regulatory designation and billing pathways that unlock consistent revenue. A major theme in the conversation is conversion strategy. Shelton discusses how pharmacies can transition into LTC@Home providers by aligning operations with compliance standards, documentation requirements, and payer expectations. This includes setting up the right workflows, leveraging technology for med management and reporting, and ensuring staff are trained to operate within an LTC framework. Importantly, these conversions are not out of reach—they are highly achievable with the right guidance, and they allow pharmacies to immediately begin capturing value for existing services. The financial upside is significant. LTC@Home opens access to enhanced reimbursement models, service-based payments, and stronger payer relationships, especially within Medicare Advantage and managed care environments. Shelton emphasizes that pharmacies are leaving money on the table by not formalizing these services—and that LTC@Home is a direct path to correcting that. Strategically, this model positions community pharmacy at the center of aging-in-place healthcare, one of the fastest-growing segments in the industry. As more patients remain in their homes rather than institutional settings, pharmacies that adapt to LTC@Home will become essential care hubs—supporting not just medication dispensing, but ongoing clinical and logistical care. The takeaway is clear: LTC Pharmacy at Home is not just an opportunity—it’s a directional shift for the profession. Pharmacies that move early can differentiate, stabilize revenue, and deepen their role in patient care, while those that delay risk being left behind as the model becomes standard.

Re-introducing Dr A back to host Sex PharmD. Sex Therapy 101 and the 5 Love Languages

Soda boosting testosterone sounds like the perfect "have your cake and eat it too" health hack, but is there any actual science behind the viral headlines? We’re breaking down the mouse study that set the internet on fire and comparing it to massive human data that tells a completely different, and much darker, story for your hormones. A 2022 study found that mice drinking 100% Coke or Pepsi actually had larger testicles and higher testosterone levels. But before you go buy a 12-pack, you need to realize that men are not mice, and what works in a 15-day rodent trial often fails miserably in humans. In fact, when we look at data from thousands of men, the reality is that high sugary drink consumption is linked to more than double the risk of clinically low testosterone. We dive into why the sugar in your soda fuels obesity and insulin resistance—two of the biggest "testosterone killers" on the planet. This show is intended for educational and informational purpose Website: https://RatedRxMedia.com YouTube: https://www.youtube.com/@RatedRxMedia Instagram: https://www.instagram.com/ratedrxmedia/ TikTok: https://www.tiktok.com/@ratedrxmedia/ Facebook: https://www.facebook.com/people/Rated-Rx/61574813907982/ Spotify: https://open.spotify.com/show/7KATtG1c3HwwYpVMtRuNub Apple Podcasts: https://podcasts.apple.com/us/podcast/rated-rx/id1804181016

In this industry-focused, conversational interview, Pharmacy Podcast Network Host Todd Eury speaks with Stephen Beckman, CEO of YARAL Pharma. The discussion explores YARAL Pharma’s commitment to continuity of supply, how consistent on-time delivery supports pharmacy operations, and the company’s philosophy of “Doing Things Differently” — redefining what it means to be a trusted generics partner.